China Oncology Drugs Market: Opportunity Analysis and Industry Forecast, 2019-2026
The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 ...
Report Code : A04505 | Pages : 135 | Category : Life Sciences
Japan Oncology Drugs Market: Opportunity Analysis and Industry Forecast, 2019–2026
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Report Code : A05277 | Pages : 147 | Category : Life Sciences
Top 10 Cancer Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023–2032 : Global Opportunity Analysis and Industry Forecast, 2023–2032
The top 10 cancer drugs market size was valued at $77.9 billion in 2022 and is estimated to reach $198.8 billion by 2032, exhibiting a CAGR of 10.0% ...
Report Code : A05860 | Pages : 190 | Category : Life Sciences
Folliculotropic Mycosis Fungoides Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Folliculotropic mycosis fungoides is a type of cutaneous T-cell lymphoma. This is a rare disease in which white blood cells (WBC) turn into cancerous cell due genetic mutation. ...
Report Code : A13192 | Category : Life Sciences
HER2-Positive Breast Cancer Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Human epidermal growth factor receptor 2 (HER2) is a gene that is linked to breast cancer development. Genes contain the recipes for numerous proteins required by a cell to remain healthy and function normally.
Report Code : A15411 | Category : Life Sciences
Neuroblastoma Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
The global neuroblastoma drugs market was valued at $0.7 billion in 2022, and is projected to reach $1.3 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.
Report Code : A172697 | Pages : 256 | Category : Life Sciences
